ARCHIVES

Committee Unblinds Phase III Zytiga Study

This article is from The Cancer Letter archive.

Vol. 35 No. 3 | March 30, 2012

Download PDF Visit The Full Archive

Related Articles

Report Redefines Cancer Control Research, Sets the Agenda For Newest NCI Division

October 17, 1997

NCI Programs: Institute To Contact For Software To Control Ultrasound Imaging

November 19, 1999

Officals: “Separations” in Normal Range as Critics Claim Brain Drain in the Clinic

January 17, 2014

Pesticides Not Linked To High Rates Of Breast Cancer.

May 18, 2001

BMS Agent Yervoy Received FDA Approval for Metastatic Melanoma

March 25, 2011

VeriStrat Biomarker Test Predicts Treatment Outcomes In Phase III NSCLC Trial

May 30, 2014